What's Next for Affymax, Inc. (AFFY)?
Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients. The drug enters a war against Amgen, Inc.
Davita Inc. (DVA)
Market is closed
Billionaire Hedge Funds
